Bio-Rad Laboratories, Inc.
BIO
Κατάταξη σε μετοχές
#2158
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules,... Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
Τιμή μετοχής
$354.75
Τελευταίος συγχρονισμός: 2026-10-20
Κεφαλαιοποίηση
$9.49B
Αλλαγή (1 ημέρα)
0.76%
Αλλαγή (1 έτος)
7.09%
Χώρα
US
Εμπόριο Bio-Rad Laboratories, Inc. (BIO)
Κατηγορία
Healthcare
Έσοδα για την Bio-Rad Laboratories, Inc. (BIO)
Έσοδα τον Jun 2026 TTM: $2.59B
Σύμφωνα με τις τελευταίες οικονομικές αναφορές της Bio-Rad Laboratories, Inc., τα τρέχοντα έσοδα της εταιρείας (TTM) είναι $2.59B. Το 2024, η εταιρεία είχε έσοδα $2.57B μείωση σε σύγκριση με τα έσοδα του έτους 2023, τα οποία ήταν $2.67B. Τα έσοδα είναι το συνολικό ποσό που παράγει μια εταιρεία από τις πωλήσεις προϊόντων ή υπηρεσιών. Σε αντίθεση με τα κέρδη, δεν αφαιρούνται έξοδα.
Ιστορικό εσόδων για την Bio-Rad Laboratories, Inc. από 2000 έως 2026
Έσοδα στο τέλος κάθε έτους
| Έτος | Έσοδα | Αλλαγή |
|---|---|---|
| 2026 (TTM) | $2.59B | 0.24% |
| 2025 | $2.58B | 0.65% |
| 2024 | $2.57B | -3.92% |
| 2023 | $2.67B | -4.67% |
| 2022 | $2.80B | -4.12% |
| 2021 | $2.92B | 14.81% |
| 2020 | $2.55B | 10.12% |
| 2019 | $2.31B | 0.94% |
| 2018 | $2.29B | 6.02% |
| 2017 | $2.16B | 4.45% |
| 2016 | $2.07B | 2.41% |
| 2015 | $2.02B | -7.15% |
| 2014 | $2.18B | 1.99% |
| 2013 | $2.13B | 3.07% |
| 2012 | $2.07B | -0.21% |
| 2011 | $2.07B | 7.60% |
| 2010 | $1.93B | 8.01% |
| 2009 | $1.78B | 1.13% |
| 2008 | $1.76B | 20.76% |
| 2007 | $1.46B | 14.69% |
| 2006 | $1.27B | 7.87% |
| 2005 | $1.18B | 8.35% |
| 2004 | $1.09B | 8.63% |
| 2003 | $1.00B | 12.40% |
| 2002 | $892.72M | 9.20% |
| 2001 | $817.51M | 12.62% |
| 2000 | $725.88M | 0.00% |
Έσοδα για παρόμοιες εταιρείες ή ανταγωνιστές
| Εταιρεία | Έσοδα | Διαφορά Εσόδων | Χώρα |
|---|---|---|---|
| $46.59B | 1,699.13% |
US
|
|
| $35.48B | 1,270.41% |
IE
|
|
| $25.84B | 897.84% |
US
|
|
| $21.00B | 710.88% |
US
|
|
| - | - |
DE
|
